THE VIRCHOW GROUP with an operational experience of over 4 decades has a global footprint in over 100 countries supporting about 3,500 employees with an annual turnover of over $750 million. The Virchow Group has a diversified business portfolio ranging from Biogenerics, Pharmaceuticals, Medical devices, and APIs. The group is the largest producer of Sulfamethoxazole and Ranitidine Hydrochloride in the world.